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Abstract
Introduction
Extensive antibiotic use makes the intensive care unit (ICU) an important focus for antibiotic
stewardship programs. The aim of this study was to develop a set of actionable quality indi-
cators for appropriate antibiotic use at ICUs and an implementation toolbox, which can be
used to assess and improve the appropriateness of antibiotic use in the treatment of adult
patients at an ICU.
Methods
A four round modified-RAND Delphi procedure was used. Potential indicators were identi-
fied by a multidisciplinary panel of 15 Dutch experts, from international literature and guide-
lines. Using an online survey, the identified indicators were rated on three criteria:
relevance, actionability and feasibility. Experts discussed and rated the indicators for the
second time during a face-to-face consensus meeting. During a final consensus meeting
the toolbox was developed, containing potential barriers and improvement strategies which
were identified using a validated checklist by Flottorp et al., and if available also containing
supporting material.
Results
The first round resulted in 24 potential indicators. After the final meeting a set of three pro-
cess indicators, one structure indicator and one quantity metric remained: 1) perform at
least two sets of blood cultures before start of empirical systemic therapy; 2) perform
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therapeutic drug monitoring in patients treated with vancomycin or aminoglycosides; 3) per-
form surveillance cultures if selective digestive or oropharyngeal decontamination is applied
at the ICU; 4) biannual face-to-face meetings between ICU and microbiology staff in which
local resistance rates are discussed; and 5) quantitative antibiotic use at the ICU expressed
in days of therapy (DOT). The toolbox contains 24 unique barriers and 37 improvement
strategies.
Conclusions
Our study identified a set of four actionable quality indicators and one quantity metric,
together with an implementation toolbox, to improve appropriate antibiotic use at ICUs.
Introduction
Infection is a major cause of morbidity and mortality in critically ill patients, resulting in a
high percentage of patients using antibiotics in intensive care units (ICUs), up to 71% [1].
Inappropriate use of antibiotics is the main driving force in the emergence and spread of resis-
tant microorganisms, which makes the intensive care an important focus for antibiotic stew-
ardship programs (ASPs) [2]. ASPs are coordinated programs designed to improve the
appropriate use of antibiotics at an institutional level [3]. Integration of ASPs in the ICU is
essential in order to pursue optimal antibiotic use in critically ill patients.
A requirement for an effective stewardship program is the ability to measure the appropri-
ateness of antibiotic use. Quality indicators are defined as measurable elements designed to
evaluate aspects of quality of care [4]. Previous studies have developed indicators to measure
appropriate antibiotic use in hospitalized non-ICU adults. These studies showed large varia-
tion in quality of antibiotic use between hospitals and thus considerable room for improve-
ment [5–8]. In addition, studies illustrated that the use of quality indicators improves the
appropriateness of antibiotic use and is associated with a decreased length of hospital stay [9,
10]. The Organisation for Economic Cooperation and Development (OECD) and the Agency
for Healthcare Research and Quality (AHRQ) have defined criteria for good quality indicators:
a good indicator should be relevant, actionable, reliable, show room for improvement and data
collection should be feasible [11, 12]. Literature points out that actionability, meaning that the
indicator offers clear direction to improve performance in daily practice, specifically contrib-
utes to the success of quality improvement [13, 14].
Indicator scores can be used to develop tailored interventions. Tailored interventions are
designed to achieve improvements in healthcare, based on the assessment of local barriers in
clinical practice [15]. Systematic tailoring of improvement strategies entails three key steps: 1)
identification of the barriers of practice (e.g. factors that hinder the performance of recom-
mended appropriate antibiotic use), 2) designing interventions targeted at these barriers, and
3) application and assessment of the effects of the interventions [15, 16]. However, several fac-
tors such as time and resource constraints, lack of knowledge on how to improve, and insuffi-
cient involvement of staff members hamper health care professionals to develop and execute
improvement strategies [14, 17]. Current literature suggests that providing a pre-established
list with barriers that might hinder performance on a quality indicator and a list with suggested
improvement strategies to overcome these barriers can support health care providers during
the process of quality improvement [18].
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The aim of this study was to develop a set of actionable quality indicators and an implemen-
tation toolbox, which can be used to assess and improve the appropriateness of antibiotic use
in the treatment of adult patients at an ICU.
Materials and methods
We performed a modified-RAND Delphi procedure, consisting of four rounds, to develop
quality indicators and a toolbox for appropriate antibiotic use in the treatment of critically ill
patients at an adult ICU [19–21]. An overview of the RAND-modified Delphi procedure is
shown in Fig 1.
Round 1: Identification of potential indicators
First, we performed an inventory of potential indicators among a panel of Dutch experts. The
multidisciplinary panel consisted of fifteen experts: three anesthesiologists-intensivists, three
internist-intensivists, one intensivist-infectious diseases physician, three internists-ID (infec-
tious diseases) physicians, two clinical microbiologists and three clinical pharmacists. The pan-
elists were invited based on their (inter)national involvement in guideline development,
working groups or societies regarding antibiotic use or intensive care (e.g. the National Inten-
sive Care Evaluation (NICE) foundation, the Dutch Working Party on Antibiotic Policy
(SWAB) or the European Society of Clinical Microbiology and Infectious Diseases (ESC-
MID)). They represent nine university and non-university hospitals. The experts were
instructed to individually propose potential quality indicators representing appropriate antibi-
otic use, based on their knowledge and expertise in the field. In addition, we performed a sys-
tematic literature search in Medline to identify already available indicators on appropriate
antibiotic use. The search included all articles available in Medline up to January 2014. The
search was updated in April 2017, which showed no additional indicators relating to antibiotic
use at the ICU since 2014. The search strategy is listed in Table 1. Two authors (MK and MJB)
independently screened title and abstract in order to identify studies that described (the devel-
opment of) indicators for appropriate antibiotic use at the ICU. We included all articles that
concerned antibiotic use, quality indicators and critical care. Antibiotics were defined as anti-
bacterial agents or antimicrobial agents. Quality indicators were defined as quality measures,
performances measures or criteria. Critical care was defined as critical care unit or intensive
care unit. Articles were excluded if they were case reports, were not written in English or
Dutch, did not concern antibiotic use, critical care, or performance measures, or if they con-
cerned only a specific subgroup of patients. Duplicate studies were removed. We reviewed
potentially relevant articles, including references, in full-text format. Third, we made an
expert-based selection of national and international guidelines regarding antibiotic use in criti-
cally ill patients, from which we extracted all potential indicators (see S1 Appendix). Finally, a
list with potential indicators was composed, for which indicators were rephrased if needed and
duplicate indicators were removed.
Round 2: Online survey
In the second round we converted the list with potential quality indicators into an online sur-
vey and instructed experts to appraise each indicator. Based on a 9-point Likert scale (1 = totally
disagree, 9 = totally agree), the experts independently rated the potential indicators on two cri-
teria: 1) relevance, the impact of the indicator on disease or on healthcare expenditure and 2)
actionability, the extent to which an indicator offers direction for improvement in clinical
practice. Indicators with a median score between 4–9 on both relevance and actionability were
defined as potentially suitable and indicators with a median score between 1–4 were defined as
Quality indicators and an action implementation toolbox for appropriate antibiotic use at intensive care units
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Fig 1. RAND-modified Delphi procedure for the development of quality indicators (QIs) and an action implementation toolbox.
https://doi.org/10.1371/journal.pone.0207991.g001
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not suitable [21]. We selected all potentially suitable indicators for the expert panel meeting
(see Table 2).
Round 3: Expert panel consensus meeting
During a face-to-face consensus meeting held on October 1st 2015, we presented the results of
the second round to the expert panel. All 15 experts from round 2 were invited, and 10 of
them were available at the selected meeting date. The indicators were discussed, rephrased,
merged and rated for the second time based on three criteria: 1) relevance, 2) actionability and
3) feasibility of data collection, the ability to use routinely collected electronic data. In addition,
the experts appraised each indicator with a validity score, reflecting whether the indicator is
associated with and appears to measure quality of antibiotic use in clinical practice (i.e. face
and content validity). A blinded survey tool was used to support independent rating. After the
second rating all indicators with median scores of 7–9 on relevance, actionability and feasibil-
ity without disagreement (i.e. 80% of the assessment rates were within the range of the median
scores of 7–9), together with a validity score in the highest quartile of all validity scores, were
selected (see Table 2) [21]. The selected indicators were described in detail according to the
AIRE instrument, including definitions, in-and exclusion criteria, target values, important
case-mix variables and subgroups [4]. If an indicator reflected the degree in which antibiotic
use was appropriate and was accompanied by a clear target value, it was defined as a quality
indicator. If an indicator reflected the volume of antibiotic use, and its outcome only gained
value when comparing it among ICUs, it was defined a quantity metric. Results of the consen-
sus meeting were send to all 15 panel members for their final approval.
Round 4: Action implementation toolbox
Flottorp et al. developed a checklist with all possible barriers for practice and improvement
strategies to overcome these barriers, by performing an extensive systematic review of frame-
works of determinants of practice followed by a consensus procedure [15]. Based on this vali-
dated checklist and expert opinion we defined per selected indicator a list with all possible
barriers that can lead to poor performance on that indicator, and a list with improvement
strategies to overcome these specific barriers. The list with barriers and improvement strategies
was discussed during a second face-to-face meeting. All 15 experts from round 2 were invited,
Table 1. Search strategy in Medline performed in January 2014. Limits: adults, English, Dutch.
Quality indicator AND Antibiotic AND Critical care AND Development
1. quality indicator[Mesh] OR 11. Antibiotic� OR 22. Critical care[Mesh] OR 26. develop�
2. quality criterion OR 12. “Antimicrobial agents” OR 23. Intensive care units[Mesh] OR
3. quality measure� OR 13. “Antimicrobial drugs” OR 24. “Intensive care medicine” OR
4. performance indicator OR 14. “Antibacterial drugs” OR 25. Critical illness[Mesh]
5. performance measure OR 15. “Antibacterial therapy” OR
6. outcome measure OR 16. “Antimicrobial therapy” OR
7. outcome indicator� OR 17. Anti-bacterial agents[Mesh] OR
8. audit OR 18. Anti-infective agents[Mesh] OR
9. outcome assessment[Mesh] OR 19. “Antibiotic use” OR
10. process assessment[Mesh] 20. “antimicrobial chemotherapy” OR
21. stewardship[tw] OR
22. appropriate antibiotic use[tw]
� truncation symbol = different word variations can be searched for (singular / plural / conjugations).
https://doi.org/10.1371/journal.pone.0207991.t001
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and 5 of them were available at the selected meeting date. The experts adjusted the predefined
list and suggested additional barriers and improvement strategies. Again, results of the consen-
sus meeting were send to all 15 panel members for approval and additional suggestions. The
final list with barriers and improvement strategies were grouped into four out of the seven pre-
defined categories that are considered relevant in the antibiotic care process [15]. If available,
literature or materials, e.g. posters, that could support implementation of the improvement
Table 2. Results of round 2 and 3 of the RAND-modified Delphi procedure.
Quality indicators Round 2: Online survey Round 3: Consensus meeting Result
Individual expert rating Group
discussion
Individual expert rating
Relevance
(median
score)
Actionability
(median
score)
Relevance
(median
score)
Actionability
(median
score)
Feasibility
(median
score
Validity
(median
score)
1. quantitative antibiotic use (quantity metric) 7 7 Rephrased 8,5 8 9 8 Accepted
2. quantitative use of restricted antibiotics
(quantity metric)
7 8 Merged with 1
3. ratio of restricted versus total antibiotic use 7 7 Merged with 1
4. costs of antibiotics used 5,5 5 Rejected after
discussion
5. duration of antibiotic therapy 8 8 Rephrased 8 8 2,5 4,5 Rejected
6. adequate duration of antibiotic therapy 8 8 Merged with 5
7. empirical antibiotic therapy according to
the guideline
8 8 Rephrased 8,5 8 6,5 7 Rejected
8. unnecessary vancomycin use 7,5 7,5 Rejected after
discussion
9. obtain blood cultures before start of
therapy
8 8,5 Rephrased 9 8,5 7,5 8 Accepted
10. obtain site cultures before start of therapy 7,5 8 Rephrased 8,5 7,5 4 5 Rejected
11. adequate drug levels 7 7 Merged with
12
12. adequate drug level determination for
vancomycin
7,5 8 Rephrased 8,5 8,5 9 8 Accepted
13. protocol for dose adjustment 8 8 9 9 9 7 Rejected
14. adequate dose adjustment 8 8 9 8 1 4,5 Rejected
15. intravenous-to-oral switch 7 6,5 1 3 7 3 Rejected
16. application of selective digestive or
oropharyngeal decontamination
8 8 Rephrased 7,5 7 7,5 6 Rejected
17. obtain blood cultures before application of
selective digestive or oropharyngeal
decontamination
7 7 Rephrased 9 8 8 8 Accepted
18. antimicrobial stewardship specialist
present during multidisciplinary meeting
8 8 Rephrased 9 8 8,5 6,5 Rejected
19. protocol for monitoring of resistance 8 8 Rephrased 9 9 8 7,5 Accepted
20. local antibiotic guidelines 8 8 Rejected after
discussion
21. pen-to-needle time 8 7,5 9 7 3 5 Rejected
22. turn-around-times of cultures (blood
draw to lab result)
8 8 8 2,5 1 3,5 Rejected
23. turn-around-times of cultures (reception
of culture at lab to lab result)
8 7 5 1,5 1 2 Rejected
24. documentation of antibiotic plan 7,5 7,5 Rephrased 9 9 7 7 Rejected
https://doi.org/10.1371/journal.pone.0207991.t002
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strategies was provided (see S2 Appendix). The barriers, improvement strategies and support-
ing materials together form “the action implementation toolbox”.
The Medical Ethics Research Committee of the Academic Medical Center confirmed that
the Medical Research Involving Human Subjects Acts (WMO) did not apply to this study,
since the study subjects were to receive treatment according to standard care and had no bur-
den of the study (August 2016).
Results
Round 1: Identification of potential indicators
The expert panel proposed in the first round 31 unique quality indicators for appropriate anti-
biotic use, based on their clinical experience. The literature search resulted in 133 scientific
articles. Based on predefined exclusion criteria 105 articles were excluded. The remaining 28
articles were selected for full-text screening. Two additional articles were selected from litera-
ture references and added to the final list. Thirteen indicators were extracted from these stud-
ies. Seventy-eight indicators were extracted from six guidelines regarding antibiotic therapy in
critically ill patients (S1 Appendix). After de-duplication and rephrasing, a set of 24 potential
indicators remained (Fig 1).
Round 2: Online survey
The panel members rated the 24 potential indicators on their relevance and actionability. All
indicators were considered potentially suitable and were therefore selected for the next round
(Fig 1 and Table 2).
Round 3: Expert panel consensus meeting
During a three-hours consensus meeting all 24 indicators were discussed. As a result, three
indicators were rejected, eleven indicators were rephrased and seven interrelated indicators
were merged into three indicators. One indicator was considered a quantity metric rather than
a quality indicator, as this metric provides relevant context to the other indicators despite the
absence of a target value. Sixteen resulting unique indicators and the quantity metric were
rated for the second time. Thirteen indicators and the quantity metric received a median score
of 7 or higher on relevance, actionability and feasibility, of which four indicators and the quan-
tity metric received a validity score in the highest quartile (Fig 1, Table 2).
This resulted in a final set of three process indicators, one structure indicator and one quan-
tity metric: 1) perform at least two sets of blood cultures before start of empirical systemic ther-
apy; 2) perform therapeutic drug monitoring in patients treated with vancomycin or
aminoglycosides, within 48 hours after start of antibiotic therapy; 3) perform surveillance cul-
tures if selective digestive or oropharyngeal decontamination is applied at the ICU; 4) biannual
face-to -face meetings between IC staff and microbiology staff in which local resistance rates
and trends in the ICU population are discussed; and 5) quantitative antibiotic use at the ICU
expressed in days of therapy (DOT; one day of therapy represents the administration of a sin-
gle agent on a given day regardless of the number of doses administered or dosage strength)
[22]. Targets for indicator 1, 2 and 3 were set at 100%, which is a theoretical optimum, mean-
ing that it is not necessarily realistic but ICUs should aim to achieve this optimum. The target
for indicator 4 was based on expert opinion and set at a minimum of two meetings per year.
The quantity metric provides context for the indicators and is suitable for benchmarking
ICUs. All 15 panel members approved the detailed description of the selected indicators. The
final set of quality indicators and quantity metric is presented in Table 3.
Quality indicators and an action implementation toolbox for appropriate antibiotic use at intensive care units
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Round 4: Action implementation toolbox
The implementation toolbox shows for each indicator a list of potential barriers in the antibi-
otic care process, and associated improvement strategies to overcome these barriers. Barriers
can be applicable to more than one indicators and improvement strategies can be applicable to
more than one barrier. A total of 24 unique barriers and 37 unique improvement strategies
were identified and grouped into four categories: A) barriers related to the guidelines, e.g. the
local antibiotic guidelines are inadequate or incomplete; B) barriers related to the individual
health care professional, e.g. health care professionals are not (sufficiently) familiar with the
antibiotic protocol; C) barriers related to professional interactions, e.g. there is insufficient
communication within ICU teams; D) barriers related to incentives and resources, e.g. there is
a lack of culture media bottles at the ICU ward. Supporting materials were provided for eight
of the unique improvement strategies (S2 Appendix).
Discussion
In this study we used a modified-RAND Delphi procedure to systematically develop a set of
four actionable quality indicators and one quantity metric for appropriate antibiotic use in
adult ICUs. In addition, we developed an implementation toolbox, containing a list with possi-
ble barriers that lead to poor performance on the selected indicators, and a list with
Table 3. Final list of actionable quality indicators and quantity metric to monitor appropriate antibiotic use for bacterial infections in hospitalized adult patients
admitted at the ICU.
Quality Indicator Indicator
type
Definition Numerator Denominator Target value
1 Perform blood cultures
before start of antibiotic
therapy
Process Percentage of patients in whom
at least two sets of blood
cultures were performed before
start of empirical systemic
therapy
Number of patients in whom at
least 2 sets of blood cultures were
performed between 24 hours
before and 24 hours after
empirical systemic antibiotic
therapy was started
Total number of patients
who started with empirical
systemic antibiotic therapy
100%
2 Perform therapeutic drug
monitoring in patients
treated with vancomycin or
aminoglycosides, within 48
hours
Process Percentage of patients treated
with vancomycin or
aminoglycosides in whom drug
levels were determined within
48 hours after start of antibiotic
therapy
Number of patients treated with
vancomycin or aminoglycosides
in whom drug levels were
determined within 48 hours after
start of antibiotic therapy
Total number of patients
treated with vancomycin
or aminoglycosides
therapy for at least 48
hours
100%
3 Perform surveillance
cultures when SDD or SOD
is applied
Process Percentage of patients in whom
surveillance cultures were
obtained if selective digestive or
oropharyngeal
decontamination is applied at
the ICU
Number of patients in whom at
least one surveillance culture was
obtained from rectum, throat
and airways when selective
digestive or oropharyngeal
decontamination is applied at the
ICU
Total number of patients
in whom selective digestive
or oropharyngeal
decontamination is applied
at the ICU
100%
4 Biannual face-to -face
meetings between IC staff
and microbiology staff in
which local resistance rates
are discussed
Structure Face-to-face meetings between
IC staff and microbiology staff
in which local resistance rates
and trends in the ICU
population are discussed.
- - At least 2 times per
year
Quantity metric Definition Target value
5 Quantitative antibiotic use
expressed in DOT
Quantitative antibiotic use at the ICU expressed in days of therapy (DOT) per 100 patient-days or per 100
admissions
Specified for subgroups: 1) restricted antibiotics, 2) per diagnosis
No target value. The
metric provides
context for indicators
and is suitable for
benchmarking
https://doi.org/10.1371/journal.pone.0207991.t003
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improvement strategies to overcome these specific barriers, which can be used to support stew-
ardship actions to increase performance on antibiotic use.
A quantity metric for total antibiotic use was selected next to the four quality indicators, as
the experts found it important to include this metric that enables benchmarking and provides
context to the other indicators despite the absence of a specific target value.
Previous studies have described several quality indicators for ICUs [23–26]. De Vos et al.
developed a general set of indicators for quality of care at the ICU and used a method comparable
to ours, including established criteria in their selection process of indicators [24]. Nevertheless,
they did not use the criterion actionability, resulting in a set that did not contain clues for quality
improvement in daily practice: the set consisted mainly of structure indicators, indicators lacked
clear definitions and target values, and little or no variation in outcome of indicators was seen
between different hospitals. Furthermore, none of these indicators were related to antibiotic use
in the ICU. Berenholtz et al. also developed quality indicators focusing on care provided in the
ICU, but they focused on the whole range of treatment specifically in sepsis patients [26]. A recent
study by van den Bosch et al. was most similar to our study, as it developed a set of indicators
focusing on antibiotic treatment. Their set consists of outcome and process indicators with clear
definitions, however, they too did not take into account the actionability of indicators. Moreover,
they focused on patients with sepsis on a general medical ward or ICU, while we specifically
aimed to develop a set of indicators for the ICU [23]. We have taken into account the limitations
of previous studies and focused on the importance of actionability of indicators, in order to
develop ICU-specific indicators that give clear direction to improve quality of care [13, 14].
The use of quality indicators to measure the appropriateness of antibiotic use requires
extensive data collection from patient records, which is labor intensive [24]. Since the imple-
mentation of the NICE registry database [27], the majority of Dutch ICUs upload their patient
level data from their local electronic health records (EHRs) or patient data management sys-
tem (PDMS) through automatic data extractions, which reduces the workload significantly.
Our set of indicators had to be suitable for electronic data extraction, which therefore was an
important prerequisite to score high on ‘feasibility of data collection’. We realize that this
might be different in other countries or settings.
Not every clinical setting needs the same level of improvement. Improvement strategies
should therefore be tailored, depending on the local barriers in clinical practice. [15, 28] Litera-
ture shows that systematic tailoring of improvement strategies can improve quality of care
[29]. To our knowledge we are the first to provide an implementation toolbox that supports
ICU health care providers in the process of tailoring improvement strategies, as they can select
those potential barriers from the toolbox that are relevant to their own context, after which the
toolbox displays the suggested improvement strategies associated with the selected barriers.
We aim to continuously expand and improve the toolbox with new or revised barriers, strate-
gies and supporting materials. The validated indicators, together with the quality improvement
toolbox, will be implemented in an online quality dashboard as part of the Dutch National
Intensive Care Evaluation (NICE) registry [27] and evaluated in future work. The online dash-
board will be offered to the participating ICUs, providing for each ICU their performance
scores and benchmark information on the antibiotic indicators (e.g. the median score of all
participating ICUs and the average score of the top 10% best performing ICUs) accompanied
by a list of potential barriers in the antibiotic care process and the associated improvement
strategies to improve the performance on these indicators [30].
Our study has several strengths. First, we used a modified-RAND Delphi approach, a sys-
tematic rigorous procedure in which scientific evidence and expert opinions are combined. [5,
6, 9, 19, 20]. Our study was consistent with the validated method, nevertheless, we made a
valuable modification and extension: in contrary to previous studies, at the start of the
Quality indicators and an action implementation toolbox for appropriate antibiotic use at intensive care units
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procedure we instructed the experts to propose indicators reflecting appropriate antibiotic use
without providing them a predefined list of potential indicators from the literature. By this, we
ensured that the clinical experts raised those indicators that were most relevant in daily prac-
tice, also when these were not (yet) described in the literature. Second, we used a multidisci-
plinary expert panel, consisting of different specialties relevant for antibiotic use in the ICU.
Third, to our knowledge, we are the first to provide an additional implementation toolbox.
This tool enables health care professionals to systematically select tailored improvement strate-
gies based on local barriers.
Our study also has some limitations. First, for pragmatic reasons the literature search was
performed only in Medline. However, we used a wide range of search terms regarding quality
measurements and antibiotics and we therefore assume that the terms should identify those
studies reporting on quality indicators. Second, the Medline search was performed in 2014
when the project started. The search was therefore updated on April 5th 2017, which showed no
additional indicators relating to antibiotic use at the ICU since 2014. Third, we did not involve
ICU nurses or patients in the expert panel. In the Netherlands antibiotic agents are solely pre-
scribed by doctors. We realize that nurses are increasingly involved in antimicrobial steward-
ship and should be included in future expert panels. Patients were not involved in our expert
team as this was logistically challenging, and also given the heterogeneity of reasons for ICU
admission. Fourth, while some of our indicators have been described before and are applicable
to general wards as well as to the ICU, they were selected because they were considered particu-
larly relevant to the ICU setting based on literature and expert opinion, because they offered
direction for improvement in clinical practice and because data collection was considered feasi-
ble. Moreover, indicator 3 and 4 are specific for the ICU setting only and have not been
described as quality indicators before. Finally, although our indicators have been developed in a
national setting, our method of development was according to current international standards
and as the indicators were based on international literature, guidelines and consensus of a mul-
tidisciplinary team of experts with international experience in their field, we believe that the
resulting indicators are generalizable to other ICU settings. Furthermore, one is able to select
indicators tailored to one’s own healthcare setting (e.g. some countries do not apply SDD).
The results of our study are a first step towards the use of a new set of actionable quality indica-
tors, together with an action implementation toolbox, to monitor and improve the appropriate-
ness of antibiotic use in adult ICUs. The toolbox will support professionals in selecting
improvement strategies that work best in their setting, based on careful assessment of local barri-
ers. Clinimetric properties of the indicators and feasibility in daily practice of electronic data reuse
from the EHR or PDMS will be tested during an evaluation study using time series analysis.
Supporting information
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